Alcon, RxSight collaborate to develop adjustable presbyopia-correcting intraocular lenses

(AWP Alliance News) - Alcon entered a non-exclusive collaboration with RxSight to jointly develop adjustable presbyopia-correcting intraocular lenses for cataract patients. The partners plan to combine RxSight's post-operative light-adjustable technology with Alcon's PCIOL optical designs to let surgeons fine-tune vision outcomes after surgery.

RxSight will receive a USD 60 million upfront payment, with up to USD 140 million tied to development and regulatory milestones. Alcon will lead global commercialization, while RxSight will handle development, manufacturing, and earn royalties on net sales.

https://www.businesswire.com/news/home/20260702035569/en/

Disclaimer: This news brief was created using generative artificial intelligence. Alcon AG published the original content used to generate this news brief via Business Wire on July 06, 2026, and is solely responsible for the information contained therein.